IDiyas

For the Inventor, By the Inventor

Natick, MA, United States of America

Xiao Mei Zheng

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 10.7

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Natick, MA (US) (2014 - 2017)
  • Dover, MA (US) (2023)

Company Filing History:

goldMedal10 out of 1,970 
 
Amgen Inc.
 patents
silverMedal1 out of 124 
 
Teijin Pharma Limited
 patents
where one patent can have more than one assignee

Years Active: 2014-2023

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):
1. 11572374 - N-cyano-7-azanorbornane derivatives and uses thereof (2023-02-07),
2. 9777019 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-10-03),
3. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-08-08),
4. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),
5. 9365522 - Pyrazole amide derivative (2016-06-14),
6. 9346827 - 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use (2016-05-24),
7. 9334269 - Carboxamides as inhibitors of voltage-gated sodium channels (2016-05-10),
8. 9309263 - Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof (2016-04-12),
9. 9296759 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2016-03-29),
10. 8883782 - Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use (2014-11-11),

Title: Innovations of Inventor Xiao Mei Zheng

Introduction

Xiao Mei Zheng, based in Natick, MA, is a distinguished inventor renowned for her contributions to pharmaceutical sciences. With a remarkable portfolio of 10 patents, she has significantly advanced the understanding and treatment of various medical conditions through her innovative compounds.

Latest Patents

Xiao Mei Zheng's latest patents include groundbreaking inventions such as “N-cyano-7-azanorbornane derivatives and uses thereof.” This invention outlines a compound of a specific formula as well as pharmaceutical compositions that utilize these compounds for therapeutic applications. Additionally, she has developed compounds known as “Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use.” These compounds play a critical role in modulating Beta-secretase enzyme activity, offering potential treatments for Alzheimer's disease and similar cognitive disorders. This patent encompasses various embodiments and provides a comprehensive approach to address conditions linked with beta-secretase activity.

Career Highlights

Throughout her career, Xiao Mei Zheng has leveraged her expertise in the pharmaceutical industry while working at notable companies such as Amgen Inc. and Teijin Pharma Limited. Her innovative research focuses on the development of therapeutic agents that can significantly improve patient care and outcomes.

Collaborations

In her endeavors, Xiao Mei Zheng has collaborated with esteemed colleagues in the research field, including Ryan D. White and Oleg Epstein. These partnerships have contributed to her success and the advancement of her pioneering inventions.

Conclusion

Xiao Mei Zheng's innovative work exemplifies the spirit of invention and the potential for scientific advancements to transform healthcare. With a robust portfolio of patents, her contributions continue to pave the way for new therapeutic modalities, ultimately benefiting numerous patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…